120 related articles for article (PubMed ID: 38594080)
1. In Vitro Characterization and Rescue of VX Metabolism in Human Liver Microsomes.
Lane TR; Koebel D; Lucas E; Moyer R; Ekins S
Drug Metab Dispos; 2024 May; 52(6):574-579. PubMed ID: 38594080
[TBL] [Abstract][Full Text] [Related]
2. [Aerobic metabolism of VX and mixed function oxidases].
Fu FH; Sun MJ
Zhongguo Yao Li Xue Bao; 1990 Mar; 11(2):123-6. PubMed ID: 2275385
[TBL] [Abstract][Full Text] [Related]
3. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.
Worek F; Seeger T; Reiter G; Goldsmith M; Ashani Y; Leader H; Sussman JL; Aggarwal N; Thiermann H; Tawfik DS
Toxicol Lett; 2014 Nov; 231(1):45-54. PubMed ID: 25195526
[TBL] [Abstract][Full Text] [Related]
4. Gender difference in the pharmacokinetics and metabolism of VX-548 in rats.
Yu G; Zhou X
Biopharm Drug Dispos; 2024 Apr; 45(2):107-114. PubMed ID: 38573807
[TBL] [Abstract][Full Text] [Related]
5. Contribution of carboxylesterase and cytochrome P450 to the bioactivation and detoxification of isocarbophos and its enantiomers in human liver microsomes.
Zhuang XM; Wei X; Tan Y; Xiao WB; Yang HY; Xie JW; Lu C; Li H
Toxicol Sci; 2014 Jul; 140(1):40-8. PubMed ID: 24752505
[TBL] [Abstract][Full Text] [Related]
6. Productive reorientation of a bound oxime reactivator revealed in room temperature X-ray structures of native and VX-inhibited human acetylcholinesterase.
Gerlits O; Kong X; Cheng X; Wymore T; Blumenthal DK; Taylor P; Radić Z; Kovalevsky A
J Biol Chem; 2019 Jul; 294(27):10607-10618. PubMed ID: 31138650
[TBL] [Abstract][Full Text] [Related]
7. In vitro characterization of 4'-(p-toluenesulfonylamide)-4-hydroxychalcone using human liver microsomes and recombinant cytochrome P450s.
Lee B; Wu Z; Lee T; Tan XF; Park KH; Liu KH
Xenobiotica; 2016; 46(4):350-6. PubMed ID: 26330107
[TBL] [Abstract][Full Text] [Related]
8. Vitamin K3 (menadione) redox cycling inhibits cytochrome P450-mediated metabolism and inhibits parathion intoxication.
Jan YH; Richardson JR; Baker AA; Mishin V; Heck DE; Laskin DL; Laskin JD
Toxicol Appl Pharmacol; 2015 Oct; 288(1):114-20. PubMed ID: 26212258
[TBL] [Abstract][Full Text] [Related]
9. Hydrolysis of tetriso by an enzyme derived from Pseudomonas diminuta as a model for the detoxication of O-ethyl S-(2-diisopropylaminoethyl) methylphosphonothiolate (VX).
Hoskin FC; Walker JE; Dettbarn WD; Wild JR
Biochem Pharmacol; 1995 Mar; 49(5):711-5. PubMed ID: 7887986
[TBL] [Abstract][Full Text] [Related]
10. Effect of metoclopramide and ranitidine on the inhibition of human AChE by VX in vitro.
Bartling A; Thiermann H; Szinicz L; Worek F
J Appl Toxicol; 2005; 25(6):568-71. PubMed ID: 16167316
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine is Metabolized by Cytochrome P450 2D6, 3A4, and 2C8, and Inhibits Cytochrome P450 2D6, while its Metabolites also Inhibit Cytochrome P450 3A
Paludetto MN; Kurkela M; Kahma H; Backman JT; Niemi M; Filppula AM
Drug Metab Dispos; 2023 Mar; 51(3):293-305. PubMed ID: 36446607
[TBL] [Abstract][Full Text] [Related]
12. Enzymatic hydrolysis of Russian-VX by organophosphorus hydrolase.
Rastogi VK; DeFrank JJ; Cheng TC; Wild JR
Biochem Biophys Res Commun; 1997 Dec; 241(2):294-6. PubMed ID: 9425265
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of endosulfan-alpha by human liver microsomes and its utility as a simultaneous in vitro probe for CYP2B6 and CYP3A4.
Casabar RC; Wallace AD; Hodgson E; Rose RL
Drug Metab Dispos; 2006 Oct; 34(10):1779-85. PubMed ID: 16855053
[TBL] [Abstract][Full Text] [Related]
14. Effect of atropine, HLö 7 and HI 6 on respiratory and circulatory function in guinea-pigs poisoned by O-ethyl S-[2-(diisopropylamino) ethyl] methylphosponothioate (VX).
Worek F; Kirchner T; Szinicz L
Pharmacol Toxicol; 1994 Nov; 75(5):302-9. PubMed ID: 7870702
[TBL] [Abstract][Full Text] [Related]
15. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic neutralization of the chemical warfare agent VX: evolution of phosphotriesterase for phosphorothiolate hydrolysis.
Bigley AN; Xu C; Henderson TJ; Harvey SP; Raushel FM
J Am Chem Soc; 2013 Jul; 135(28):10426-32. PubMed ID: 23789980
[TBL] [Abstract][Full Text] [Related]
17. Post-VX exposure treatment of rats with engineered phosphotriesterases.
Stigler L; Köhler A; Koller M; Job L; Escher B; Potschka H; Thiermann H; Skerra A; Worek F; Wille T
Arch Toxicol; 2022 Feb; 96(2):571-583. PubMed ID: 34962578
[TBL] [Abstract][Full Text] [Related]
18. VX-509 (Decernotinib)-Mediated CYP3A Time-Dependent Inhibition: An Aldehyde Oxidase Metabolite as a Perpetrator of Drug-Drug Interactions.
Zetterberg C; Maltais F; Laitinen L; Liao S; Tsao H; Chakilam A; Hariparsad N
Drug Metab Dispos; 2016 Aug; 44(8):1286-95. PubMed ID: 27298338
[TBL] [Abstract][Full Text] [Related]
19. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions.
Labroo RB; Paine MF; Thummel KE; Kharasch ED
Drug Metab Dispos; 1997 Sep; 25(9):1072-80. PubMed ID: 9311623
[TBL] [Abstract][Full Text] [Related]
20. In vitro metabolic profiling of synthetic cannabinoids by pooled human liver microsomes, cytochrome P450 isoenzymes, and Cunninghamella elegans and their detection in urine samples.
Gaunitz F; Dahm P; Mogler L; Thomas A; Thevis M; Mercer-Chalmers-Bender K
Anal Bioanal Chem; 2019 Jun; 411(16):3561-3579. PubMed ID: 31183523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
